Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Gross Profit Growth

-67.64%

Quarterly · Period ending:

LCTX logo

LCTX Gross Profit Growth

Year-over-year change vs the same period a year earlier

Latest reported-67.64%
LCTX Quarterly Gross Profit YoY % (0.00% → -67.64%)
High-resolution chart · PNG

LCTX gross profit growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Gross Profit Growth — Quarterly
Period endingGross Profit Growth
-67.6449%
4.8431%
141.0464%
-1.7375%
99.8534%
25.1921%
63.79%
247.3538%
-55.9716%
-48.3458%
-8.6045%
-61.0206%
-28.5846%
-55.2065%
139.8148%
127.0337%
1,272.7848%
2,696.1326%
1,353.8462%
407.0833%
1,216.6667%
151.3889%
-92.6657%
133.0097%
-83.2168%
-35.1351%
495.7983%
-55.0218%
-71.4%
-58.2707%
-76.8932%
-44.2822%
32.9787%
-17.3913%
-30.2168%
23.7952%
-8.5158%
-10.8033%
82.2222%
-18.6275%
31.7308%
19.7553%
83.0657%
30.509%
44.8461%
-16.0457%
-78.6859%
-9.895%
-37.0235%
5.174%
190.0869%
-58.3898%
-63.9868%
-44.1866%
-78.0637%
-25.8525%
29.971%
-25.8239%
14.9554%
37.9321%
7.4174%
7.4958%
89.3564%
82.393%
57.439%
158.5156%
162.6686%
4.6991%
5.2433%
-22.1184%
-20.4291%
84.6915%
94.8188%
55.0757%
-25.3205%
-22.1676%
47.1706%
1.6365%
115.8545%
23.526%
-42.5552%
26.5115%
15.8633%
41.1143%
27.6123%
46.1997%
-24.017%
55.0751%
100.7636%
35.2694%
37.9534%
27.9895%
59.9964%
68.8163%
246.5221%
135.7288%
102.9909%
75.0573%
-26.415%
88.2158%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.